|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0034656,
umls-concept:C0045093,
umls-concept:C0123931,
umls-concept:C0205195,
umls-concept:C0205390,
umls-concept:C0220647,
umls-concept:C0449695,
umls-concept:C1257890,
umls-concept:C1274040,
umls-concept:C1556084,
umls-concept:C2603343
|
|
pubmed:issue |
18
|
|
pubmed:dateCreated |
2003-9-15
|
|
pubmed:abstractText |
To evaluate the efficacy and toxicity of novel chemotherapy combinations including cisplatin with gemcitabine (GC) or irinotecan (IC) for patients with carcinomas of an unknown primary site.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AllouacheJelilaJ,
pubmed-author:BouzyJeannineJ,
pubmed-author:BugatRolandR,
pubmed-author:CoudertBrunoB,
pubmed-author:CulineStéphaneS,
pubmed-author:DouillardJean-YvesJY,
pubmed-author:FizaziKarimK,
pubmed-author:GoupilAlainA,
pubmed-author:KaminskyMarie-ChristineMC,
pubmed-author:LaplancheAgnèsA,
pubmed-author:LesimpleThierryT,
pubmed-author:LortholaryAlainA,
pubmed-author:MerroucheYacineY,
pubmed-author:NégrierSylvieS,
pubmed-author:PetrowPeterP,
pubmed-author:PivotXavierX,
pubmed-author:PriouFrankF,
pubmed-author:ThéodoreChristineC,
pubmed-author:Trial for the French Study Group on Carcinomas of Unknown Primary...,
pubmed-author:VialaJulietteJ,
pubmed-author:VoigtJean-JacquesJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3479-82
|
|
pubmed:dateRevised |
2009-6-26
|
|
pubmed:meshHeading |
pubmed-meshheading:12972523-Adult,
pubmed-meshheading:12972523-Aged,
pubmed-meshheading:12972523-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12972523-Camptothecin,
pubmed-meshheading:12972523-Cisplatin,
pubmed-meshheading:12972523-Deoxycytidine,
pubmed-meshheading:12972523-Female,
pubmed-meshheading:12972523-Humans,
pubmed-meshheading:12972523-Male,
pubmed-meshheading:12972523-Middle Aged,
pubmed-meshheading:12972523-Neoplasms, Unknown Primary
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).
|
|
pubmed:affiliation |
Department of Medical Oncology, Centre Régional de Lutte Contre le Cancer, Val d'Aurelle, Parc Euromédecine, 34298 Montpellier Cedex 5, France. stculine@valdorel.fnclcc.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
